Nous contacter

Tel. +33(0)2 53 00 91 22

Mob. +33(0)6 83 82 26 78

Mail: contact@labcom-risca.com

  • LinkedIn Social Icône
  • Facebook
  • Twitter
  • YouTube

Qui sommes-nous ?

s'INSCRIRE à NOTRE NEWSLETTER?

Le laboratoire SPHERE (methodS for Patients-centered outcomes and HEalth REsearch, INSERM UMR 1246, Université de NantesUniversité de Tours) et la société IDBC (groupe A2com) ont décidé de créer ensemble le Laboratoire Commun RISCA (Research in Informatics and Statistics for Cohort-based Analyses)

 

Home > Presentation > CordaBase

The CordaBase cohort

Background

The aortic valve insufficency is the most common cardiac valve pathology. It concerns 2 to 3% of the French population older than 65 years and requires the implantation of a biological valve to avoid progression to heart failure.
An average of 12,000 replacements are made each year in France. Unfortunately, all bio-prosthetics are subject to a risk of structural valve deterioration (SVD).

Objective

The objective is to improve the management of future patients by selecting more reliable biological prostheses and to better understand the determinants of their evolution.

Studied population

700 patients opérés au CHU de Nantes pour une une pose de valve cardiaque biologique de type Mitroflow.
Find here a video of this surgery, performed and commented by Thomas Sénage. The video was realized by the "Pôle Audiovisuel & Multimédia" of Nantes University.

Coordinator

Thomas Sénage
Cardiac surgeron

Thomas.SENAGE@chu-nantes.fr

Researcher - UMR 1246 SPHERE « MethodS for Patients-centered outcomes and HEalth REsearch».